
Skin cancer vaccine FDA approved by June 30, 2027?
2 of 3 top Polymarket traders hold No (67%) · No at 86¢ · $9K held · ends Jul 1, 2027
⚖️
Neutral
No
3
No 67%
$9.4K
$634.15
82.7¢ → 86¢
+4% since entry · 2 traders
Backtest pattern (not confirmed)
NeutralNo at 86%
No measured edge, which here means a loss: the plain consensus (5+ holders, 60 %+, held to resolution) lost −3.0 % a trade after costs out of sample in the full-year test (n 86,296, 95 % CI −3.6 to −2.4 %).
- Fewer than 5 holdersEvery backtest needed 5+ holders; with fewer nothing was measured.
- Favourite (60–95¢)Full year, out of sample: 0.70–0.90 lost −0.9 % a trade (n 26,050, 95 % CI −1.5 to −0.3): the least bad band, still a loss. The Oct 22 backtest's +0.4 % (n 4,327) was not confirmed.
The rules come from our Oct 22 2026 backtest (one entry per market, held to resolution, after a 1¢ half-spread and Polymarket's taker fees). Our full-year test without hindsight (Oct 26 2026) found none of them profitable out of sample, and the plain consensus lost −3.0 % a trade. The grade describes the market; it is not a forecast, not an edge and not advice.
Smart Money Signal
2 of 3 top traders (67%)1 holds an outcome priced under 50%
Outcome Probabilities
Smart Money Breakdown by Outcome
| Trader | Position | Invested | Value | PnL | Record |
|---|---|---|---|---|---|
![]() AllByMyseIf | Noavg 83.1¢ | $14.5K | $8.2K | +$562.56 | 68% 340-163 (503) |
0X 0xc7D02944A76B9F83B199e9090ECC92C82d241F8a-1776944395495CTR | Yesavg 13.8¢ | $749.85 | $762.86 | +$13.01 | 35% 121-221 (342) |
XT xtxpleasecallme | Noavg 75.2¢ | $412.19 | $370.77 | +$58.58 | 38% 5982-9836 (15818) |
Chat
EV Calculator
Consensus % is how many tracked traders hold a side, not a win probability.
86.0¢ price + 1.0¢ spread + 0.6¢ fee (Other / General 5%). Win more often than this and the bet pays.
A market order pays the taker fee and crosses the spread (assumed 1.0¢); a limit order pays no fee but may not fill. The fee category is a guess from the title.
